Carmignac Gestion Eli Lilly & CO Transaction History

Carmignac Gestion

$5.82 Billion
Q3 2024

A detailed history of Carmignac Gestion transactions in Eli Lilly & CO stock. As of the latest transaction made, Carmignac Gestion holds 136,951 shares of LLY stock, worth $110 Million. This represents 2.08% of its overall portfolio holdings.

Number of Shares

136,951

Previous 114,393 19.72%

Holding current value

$110 Million

Previous $104 Million 17.15%

% of portfolio

2.08%

Previous 1.81%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $17.4 Million - $21.7 Million	22,558 Added 19.72%	136,951 $121 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $209 Million - $263 Million	-288,811 Reduced 71.63%	114,393 $104 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $240 Million - $322 Million	-405,994 Reduced 50.17%	403,204 $314 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $39.8 Million - $46.9 Million	-75,754 Reduced 8.56%	809,198 $472 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $29.6 Million - $40.8 Million	-68,070 Reduced 7.14%	884,952 $475 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $28.3 Million - $37.8 Million	80,579 Added 9.24%	953,022 $447 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $77.8 Million - $91.4 Million	250,413 Added 40.26%	872,443 $300 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $26.3 Million - $30.6 Million	-81,702 Reduced 11.61%	622,030 $228 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $25.2 Million - $28.7 Million	-85,006 Reduced 10.78%	703,732 $228 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $3.2 Million - $3.76 Million	11,496 Added 1.48%	788,738 $256 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $109 Million - $135 Million	464,204 Added 148.29%	777,242 $223 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $70.4 Million - $87.4 Million	313,038 New	313,038 $86.5 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $108 Million - $134 Million	-1,008,978 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $108 Million - $117 Million	1,008,978 New	1,008,978 $113 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Carmignac Gestion with notifications on news.

Account

Carmignac Gestion Eli Lilly & CO Transaction History